
With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

The drug could be an effective analgesia with a safety profile that could fundamentally alter the landscape of pain management and addiction treatment.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

Community pharmacists deliver fast wound assessment, OTC guidance, and prevention tips, supporting safe healing when clinics are closed and care feels urgent.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

Community pharmacy workflows can support medical billing and new clinical services, empowering technicians and freeing pharmacists for patient care.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Chad Worz, PharmD, BCGP, FASCP, and Jeffrey Hogan, present on the implications behind major PBM reform signed in February and how the reimbursement landscape is expected to shift.

Non-high-density lipoprotein cholesterol matters in type 2 diabetes care and can be managed with statins, combination therapy, and omega‑3s.

Matt Sample and Neal Cooper join to discuss the beginning stages of the FDA’s 7-year rollout of new NDCs for prescription drugs.

Meta-analysis shows PCV13 followed by PPSV23 boosts pneumococcal immunity in seniors without added adverse effects.

This decision marks a historic milestone as sparsentan becomes the first and only medication specifically approved for this rare and devastating condition.

Community pharmacists guide minor wound care—clean, protect, and monitor—spot infection risks, and refer serious injuries quickly to prevent complications.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

Pharmacists can help cut prescription abandonment with proactive benefit checks, prior authorization help, and copay assistance.

Pharmacists can help to choose the right ingredient and avoid drug interactions for OTC relief for gas, motion sickness, nausea, and heartburn.

FDA-approved atrasentan cuts proteinuria in IgA nephropathy, with ALIGN trial results, safety insights, and dosing cautions.

Tentative FDA nod for generic semaglutide signals more glucagon-like peptide-1 access, easing pharmacy hurdles and curbing risky compounded alternatives.

Meta-analysis shows CGM lowers HbA1c and hypoglycemia in insulin-treated type 2 diabetes, while pharmacists tackle training, costs, and skin issues.

Researchers assess medication adherence across initial combination therapy users during their first year of type 2 diabetes treatment.

Social determinants of health shape pneumococcal risk, making vaccination especially important for specific populations.

With persistent challenges in the arena of US maternal health care, researchers assess pharmacists’ knowledge, confidence, and perceived barriers in filling maternal health gaps.

Pharmacists expand vaccine access, but billing rules, payer barriers, and uneven reimbursement keep immunization services from scaling nationwide.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

Lunsekimig cuts asthma exacerbations and boosts lung function while improving nasal polyps—an emerging dual-target biologic for respiratory care.

Episode 9 dives into the landscape of obesity pharmacotherapy, detailing current therapies, clinical updates, future pipelines, and more.

As debates heat up between anti-abortion and pro-life advocates, the federal government places a hold on any action toward mifepristone’s approval.

Community pharmacists weave brief lifestyle coaching and point-of-care testing into medication management, improving diabetes and hypertension outcomes.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.